tiprankstipranks
Trending News
More News >
CombiGene AB (DE:COJ0)
:COJ0
Germany Market

CombiGene AB (COJ0) Income Statement

Compare
0 Followers

CombiGene AB Income Statement

Last quarter (Q4 2024), CombiGene AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, CombiGene AB's net income was kr-14.16M. See CombiGene AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 326.00Kkr 5.54Mkr 26.70Mkr 84.04Mkr 10.83M
Gross Profit
kr 326.00Kkr -21.29Mkr -19.20Mkr 15.16Mkr 8.33M
Operating Expenses
kr 47.54Mkr 18.77Mkr 46.66Mkr 63.45Mkr 29.36M
Depreciation and Amortization
kr 13.00Mkr 329.34Kkr 300.00Kkr 2.59Mkr 2.49M
EBITDA
kr -34.22Mkr -35.98Mkr -5.86Mkr 23.56Mkr -25.66M
Operating Income
kr -47.22Mkr -36.31Mkr -6.95Mkr 20.96Mkr -28.16M
Other Income/Expenses
kr 2.34Mkr 639.76Kkr 11.01Mkr 24.00kr -2.49M
Pretax Income
kr -44.88Mkr -35.67Mkr -6.16Mkr 20.96Mkr -29.55M
Net Income
kr -44.88Mkr -35.67Mkr -5.37Mkr 20.96Mkr -30.77M
Per Share Metrics
Basic EPS
kr -2.27kr -1.80kr -0.27kr 1.21kr -3.34
Diluted EPS
kr -2.27kr -1.80kr -0.27kr 1.21kr -3.34
Weighted Average Shares Outstanding
19.80M 19.80M 19.80M 17.31M 9.23M
Weighted Average Shares Outstanding (Diluted)
19.80M 19.80M 19.80M 17.31M 9.23M
Currency in SEK

CombiGene AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis